OBJECTIVE: We examined the associations of objectively measured sedentary time, light-intensity physical activity, and moderate- to vigorous-intensity activity with fasting and 2-h postchallenge plasma glucose in Australian adults. RESEARCH DESIGN AND METHODS: A total of 67 men and 106 women (mean age +/- SD 53.3 +/- 11.9 years) without diagnosed diabetes were recruited from the 2004-2005 Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Physical activity was measured by Actigraph accelerometers worn during waking hours for 7 consecutive days and summarized as sedentary time (accelerometer counts/min <100; average hours/day), light-intensity (counts/min 100-1951), and moderate- to vigorous-intensity (counts/min > or =1,952). An oral glucose tolerance test was used to ascertain 2-h plasma glucose and fasting plasma glucose. RESULTS: After adjustment for confounders (including waist circumference), sedentary time was positively associated with 2-h plasma glucose (b = 0.29, 95% CI 0.11-0.48, P = 0.002); light-intensity activity time (b = -0.25, -0.45 to -0.06, P = 0.012) and moderate- to vigorous-intensity activity time (b = -1.07, -1.77 to -0.37, P = 0.003) were negatively associated. Light-intensity activity remained significantly associated with 2-h plasma glucose following further adjustment for moderate- to vigorous-intensity activity (b = -0.22, -0.42 to -0.03, P = 0.023). Associations of all activity measures with fasting plasma glucose were nonsignificant (P > 0.05). CONCLUSIONS: These data provide the first objective evidence that light-intensity physical activity is beneficially associated with blood glucose and that sedentary time is unfavorably associated with blood glucose. These objective data support previous findings from studies using self-report measures, and suggest that substituting light-intensity activity for television viewing or other sedentary time may be a practical and achievable preventive strategy to reduce the risk of type 2 diabetes and cardiovascular disease.
OBJECTIVE: We examined the associations of objectively measured sedentary time, light-intensity physical activity, and moderate- to vigorous-intensity activity with fasting and 2-h postchallenge plasma glucose in Australian adults. RESEARCH DESIGN AND METHODS: A total of 67 men and 106 women (mean age +/- SD 53.3 +/- 11.9 years) without diagnosed diabetes were recruited from the 2004-2005 Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Physical activity was measured by Actigraph accelerometers worn during waking hours for 7 consecutive days and summarized as sedentary time (accelerometer counts/min <100; average hours/day), light-intensity (counts/min 100-1951), and moderate- to vigorous-intensity (counts/min > or =1,952). An oral glucose tolerance test was used to ascertain 2-h plasma glucose and fasting plasma glucose. RESULTS: After adjustment for confounders (including waist circumference), sedentary time was positively associated with 2-h plasma glucose (b = 0.29, 95% CI 0.11-0.48, P = 0.002); light-intensity activity time (b = -0.25, -0.45 to -0.06, P = 0.012) and moderate- to vigorous-intensity activity time (b = -1.07, -1.77 to -0.37, P = 0.003) were negatively associated. Light-intensity activity remained significantly associated with 2-h plasma glucose following further adjustment for moderate- to vigorous-intensity activity (b = -0.22, -0.42 to -0.03, P = 0.023). Associations of all activity measures with fasting plasma glucose were nonsignificant (P > 0.05). CONCLUSIONS: These data provide the first objective evidence that light-intensity physical activity is beneficially associated with blood glucose and that sedentary time is unfavorably associated with blood glucose. These objective data support previous findings from studies using self-report measures, and suggest that substituting light-intensity activity for television viewing or other sedentary time may be a practical and achievable preventive strategy to reduce the risk of type 2 diabetes and cardiovascular disease.
Authors: A R Cooper; S Sebire; A A Montgomery; T J Peters; D J Sharp; N Jackson; K Fitzsimons; C M Dayan; R C Andrews Journal: Diabetologia Date: 2011-12-14 Impact factor: 10.122
Authors: Charles E Matthews; Stephanie M George; Steven C Moore; Heather R Bowles; Aaron Blair; Yikyung Park; Richard P Troiano; Albert Hollenbeck; Arthur Schatzkin Journal: Am J Clin Nutr Date: 2012-01-04 Impact factor: 7.045
Authors: Matthew P Buman; Eric B Hekler; William L Haskell; Leslie Pruitt; Terry L Conway; Kelli L Cain; James F Sallis; Brian E Saelens; Lawrence D Frank; Abby C King Journal: Am J Epidemiol Date: 2010-09-15 Impact factor: 4.897
Authors: Neville Owen; Phillip B Sparling; Geneviève N Healy; David W Dunstan; Charles E Matthews Journal: Mayo Clin Proc Date: 2010-12 Impact factor: 7.616
Authors: Maciej S Buchowski; Charles E Matthews; Sarah S Cohen; Lisa B Signorello; Jay H Fowke; Margaret K Hargreaves; David G Schlundt; William J Blot Journal: J Phys Act Health Date: 2011-08-02
Authors: W Jack Rejeski; Anthony P Marsh; Peter H Brubaker; Matthew Buman; Roger A Fielding; Don Hire; Todd Manini; Alvito Rego; Michael E Miller Journal: J Gerontol A Biol Sci Med Sci Date: 2015-10-29 Impact factor: 6.053